Literature DB >> 7878014

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.

M A Horwitz1, B W Lee, B J Dillon, G Harth.   

Abstract

Tuberculosis, caused by the intracellular pathogen Mycobacterium tuberculosis, is the world's leading cause of death in humans from a single infectious agent. A safe and effective vaccine against this scourge is urgently needed. This study demonstrates that immunization with the 30-kDa major secretory protein, alone or in combination with other abundant extracellular proteins of M. tuberculosis, induces strong cell-mediated immune responses and substantial protective immunity against aerosol challenge with virulent M. tuberculosis bacilli in the highly susceptible guinea pig model of pulmonary tuberculosis. Protection is manifested by decreased clinical illness including decreased weight loss, reduced mortality, and decreased growth of M. tuberculosis in the lungs and spleens of immunized animals compared with sham-immunized controls. This study demonstrates that purified major extracellular proteins of M. tuberculosis are candidate components of a subunit vaccine against tuberculosis and provides compelling support for the concept that extracellular proteins of intracellular pathogens are key immunoprotective molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878014      PMCID: PMC42553          DOI: 10.1073/pnas.92.5.1530

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  The BCG story: lessons from the past and implications for the future.

Authors:  P E Fine
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

2.  Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs.

Authors:  M K Cohen; R A Bartow; C L Mintzer; D N McMurray
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

3.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

4.  Host-parasite relationships in experimental airborne tuberculosis. V. Lack of hematogenous dissemination of Mycobacterium tuberculosis to the lungs in animals vaccinated with Bacille Calmette-Guérin.

Authors:  J S Fok; R S Ho; P K Arora; G E Harding; D W Smith
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

5.  Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals.

Authors:  D W Smith; E Wiegeshaus; R Navalkar; A A Grover
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

Review 6.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.

Authors:  A C Allison; N E Byars
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

7.  Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence.

Authors:  F M Collins
Journal:  Tubercle       Date:  1985-12

8.  Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.

Authors:  S J Blander; M A Horwitz
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.

Authors:  I M Orme; F M Collins
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  145 in total

1.  Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

Authors:  A Weinrich Olsen; L A van Pinxteren; L Meng Okkels; P Birk Rasmussen; P Andersen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG).

Authors:  G Batoni; S Esin; M Pardini; D Bottai; S Senesi; H Wigzell; M Campa
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

4.  T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs.

Authors:  B Y Lee; M A Horwitz
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

Authors:  K Pehler; K M Brasky; T M Butler; R Attanasio
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

6.  HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c.

Authors:  Michèl R Klein; Abdulrahman S Hammond; Steve M Smith; Assan Jaye; Pauline T Lukey; Keith P W J McAdam
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

Authors:  Helen McShane; Shahriar Behboudi; Nilu Goonetilleke; Roger Brookes; Adrian V S Hill
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.

Authors:  G W De Lisle; T Wilson; D M Collins; B M Buddle
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

9.  Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.

Authors:  M A Horwitz; G Harth; B J Dillon; S Maslesa-Galic'
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

10.  Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometry.

Authors:  Ying Ge; Mariam El-Naggar; Siu Kwan Sze; Han Bin Oh; Tadhg P Begley; Fred W McLafferty; Helena Boshoff; Clifton E Barry
Journal:  J Am Soc Mass Spectrom       Date:  2003-03       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.